Literature DB >> 33342584

Free of malignancy but not of fears: A closer look at Damocles syndrome in survivors of hematologic malignancies.

Mohamad S Alabdaljabar1, Ibrahim N Muhsen2, Jennifer M Knight3, Karen L Syrjala4, Shahrukh K Hashmi5.   

Abstract

Fear of cancer recurrence (FoR) is an important yet underestimated long term sequela that many cancer survivors suffer from. The continuous state of uncertainty the survivors might go through can lead to a serious impact on their quality of life (QoL), which is collectively referred to as Damocles syndrome. Given the increasing numbers of cancer survivors, it is crucial to understand the different psychological issues that face them, including Damocles syndrome. Herein, we review the current literature of Damocles syndrome specifically in hematologic cancer survivors. Although with inconsistent terms, current literature demonstrates the impact and the prevalence of Damocles syndrome on QoL of survivors of leukemia, lymphoma, and hematopoietic cell transplant. Interventional studies are very limited in this area. Moreover, hematologic malignancy survivors can also meet the diagnostic criteria of other psychiatric diseases, including depression, anxiety, and post-traumatic stress disorder, wherein they should be managed accordingly. It is important to increase the awareness about Damocles syndrome and screen patients for it and other related psychological disorders. Additionally, this review has shown the need for standardization of Damocles syndrome definitions. Finally, the lack of interventional studies that target survivors' psychosocial challenges calls for prospective research to better address this rising problem.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Damocles; Hematologic malignancy; Survivors; Sword

Year:  2020        PMID: 33342584      PMCID: PMC8166938          DOI: 10.1016/j.blre.2020.100783

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  83 in total

1.  Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B.

Authors:  A B Kornblith; J Anderson; D F Cella; S Tross; E Zuckerman; E Cherin; E Henderson; R B Weiss; M R Cooper; R T Silver
Journal:  Cancer       Date:  1992-10-15       Impact factor: 6.860

2.  An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Joan M Romano; Marie-Laure Crouch; Allison S Fiscalini; Mark T Hegel; Mary E D Flowers; Paul J Martin; Wendy M Leisenring
Journal:  J Cancer Surviv       Date:  2018-05-05       Impact factor: 4.442

3.  Fear of cancer recurrence in lymphoma survivors: A descriptive study.

Authors:  Lauren E Latella; Madeline Rogers; Howard Leventhal; Patricia A Parker; Steven Horwitz; Matthew J Matasar; Carma L Bylund; David W Kissane; Kara Franco; Smita C Banerjee
Journal:  J Psychosoc Oncol       Date:  2019-10-16

4.  Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer.

Authors:  Margaret L Stuber; Kathleen A Meeske; Kevin R Krull; Wendy Leisenring; Kayla Stratton; Anne E Kazak; Marc Huber; Bradley Zebrack; Sebastian H Uijtdehaage; Ann C Mertens; Leslie L Robison; Lonnie K Zeltzer
Journal:  Pediatrics       Date:  2010-05       Impact factor: 7.124

5.  Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers.

Authors:  Jessica Liang; Stephanie J Lee; Barry E Storer; Bronwen E Shaw; Eric J Chow; Mary E Flowers; Elizabeth F Krakow; Merav Bar; Karen L Syrjala; Rachel B Salit; Chareeni E Kurukulasuriya; Heather S L Jim
Journal:  Biol Blood Marrow Transplant       Date:  2018-08-09       Impact factor: 5.742

6.  Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients.

Authors:  Karen L Syrjala; Jean C Yi; Shelby L Langer
Journal:  Psychooncology       Date:  2015-06-29       Impact factor: 3.894

7.  Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Jennifer M Knight; J Douglas Rizzo; Brent R Logan; Tao Wang; Jesusa M G Arevalo; Jeffrey Ma; Steve W Cole
Journal:  Clin Cancer Res       Date:  2015-08-18       Impact factor: 12.531

8.  Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation.

Authors:  J Rischer; A Scherwath; A R Zander; U Koch; F Schulz-Kindermann
Journal:  Bone Marrow Transplant       Date:  2009-01-19       Impact factor: 5.483

9.  Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients.

Authors:  Hengwen Sun; Yuan Yang; Jingying Zhang; Ting Liu; Hongmei Wang; Samradhvi Garg; Bin Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-04-08       Impact factor: 2.570

10.  Sleep disruption among cancer patients following autologous hematopoietic cell transplantation.

Authors:  Ashley M Nelson; Heather S L Jim; Brent J Small; Taiga Nishihori; Brian D Gonzalez; Julie M Cessna; Kelly A Hyland; Meredith E Rumble; Paul B Jacobsen
Journal:  Bone Marrow Transplant       Date:  2017-12-21       Impact factor: 5.483

View more
  4 in total

1.  Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial.

Authors:  Christina Peters; Michael H Albert; Anna Eichinger; Ulrike Poetschger; Evgenia Glogova; Peter Bader; Oliver Basu; Rita Beier; Birgit Burkhardt; Carl-Friedrich Classen; Alexander Claviez; Selim Corbacioglu; Hedwig E Deubzer; Johann Greil; Bernd Gruhn; Tayfun Güngör; Kinan Kafa; Jörn-Sven Kühl; Peter Lang; Bjoern Soenke Lange; Roland Meisel; Ingo Müller; Martin G Sauer; Paul-Gerhardt Schlegel; Ansgar Schulz; Daniel Stachel; Brigitte Strahm; Angela Wawer
Journal:  Leukemia       Date:  2022-09-12       Impact factor: 12.883

2.  Corporeal rehabilitation to manage acute stress in critically ill patients.

Authors:  Irma Bourgeon-Ghittori; Maryline Couette; Sylvie Marini; Rachida Ouedraogo; Aline Alves; Keyvan Razazi; Damien Carras; Ann-Cecile Pallud; Nancy Kentish-Barnes; Armand Mekontso Dessap
Journal:  Ann Intensive Care       Date:  2022-06-10       Impact factor: 10.318

3.  Reducing distress and depression in cancer patients during survivorship.

Authors:  Jessica Molinaro; Anjishnu Banerjee; Stanley Lyndon; Sarah Slocum; Carrie Danhieux-Poole; Christine Restivo-Pritzl; Ann Marie Uselmann; Lyndsey Wallace; Jennifer M Knight
Journal:  Psychooncology       Date:  2021-04-08       Impact factor: 3.955

Review 4.  Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults.

Authors:  Ginna Granroth; Nandita Khera; Cecilia Arana Yi
Journal:  Curr Hematol Malig Rep       Date:  2022-09-19       Impact factor: 4.213

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.